VOYA Investment Management
URGN icon

VOYA Investment Management’s UroGen Pharma URGN Stock Holding History

VOYA Investment Management’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
71,260
+27,762
+64% +$752K ﹤0.01% 1121
2026
Q1 		$782K Sell
43,498
-33,264
-43% -$667K ﹤0.01% 1546
2025
Q4 		$1.8M Sell
76,762
-6,849
-8% -$149K ﹤0.01% 1254
2025
Q3 		$1.67M Buy
83,611
+23,297
+39% +$418K ﹤0.01% 1307
2025
Q2 		$826K Buy
60,314
+50,222
+498% +$482K ﹤0.01% 1654
2025
Q1 		$112K Sell
10,092
-1,153
-10% -$12.3K ﹤0.01% 2413
2024
Q4 		$120K Sell
11,245
-422
-4% -$5.05K ﹤0.01% 2538
2024
Q3 		$148K Buy
11,667
+49
+0.4% +$727 ﹤0.01% 2564
2024
Q2 		$195K Buy
+11,618
New +$165K ﹤0.01% 2486
2024
Q1 		– Sell
-11,080
Closed -$166K – 2888
2023
Q4 		$166K Buy
+11,080
New +$144K ﹤0.01% 2629
2021
Q4 		– Sell
-148,439
Closed -$2.5M – 2822
2021
Q3 		$2.5M Sell
148,439
-12,082
-8% -$192K 0.01% 1076
2021
Q2 		$2.45M Sell
160,521
-5,831
-4% -$105K ﹤0.01% 1111
2021
Q1 		$3.24M Sell
166,352
-181,515
-52% -$3.85M 0.01% 986
2020
Q4 		$6.27M Sell
347,867
-31,004
-8% -$650K 0.01% 738
2020
Q3 		$7.31M Buy
378,871
+89,982
+31% +$2.04M 0.02% 624
2020
Q2 		$7.55M Buy
288,889
+101,470
+54% +$2.48M 0.02% 616
2020
Q1 		$3.34M Buy
187,419
+67,377
+56% +$1.82M 0.01% 805
2019
Q4 		$4M Buy
+120,042
New +$3.28M 0.01% 871
2019
Q3 		– Sell
-6,689
Closed -$240K – 2574
2019
Q2 		$240K Buy
+6,689
New +$247K ﹤0.01% 2202

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

VOYA Investment Management's URGN Position: Q2 2026 in Review

VOYA Investment Management increased its UroGen Pharma (URGN) stake by 64% in Q2 2026, buying an estimated $752K and bringing the position to 71,260 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

VOYA Investment Management first reported a position in URGN in Q2 2019 and has held it in 19 quarters since. The position peaked at $7.55M in Q2 2020. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • VOYA Investment Management held 71,260 shares of UroGen Pharma worth $2.62M as of Q2 2026.
  • VOYA Investment Management bought 27,762 UroGen Pharma shares in Q2 2026, an estimated $752K.
  • UroGen Pharma made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1121 holding.
  • VOYA Investment Management first reported a position in UroGen Pharma in Q2 2019 and has held it in 19 quarters since.
  • VOYA Investment Management's UroGen Pharma position peaked at $7.55M in Q2 2020.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.